8-K

Company

Evofem Biosciences, Inc.

Filed

December 16, 2019

Period of Report

December 13, 2019

Accession Number

0001618835-19-000217

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →